DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice

Information source: Consorci Sanitari de Terrassa
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gynecological Pathology

Intervention: Lidocaine-Prilocaine cream (Drug); placebo (Drug)

Phase: Phase 4

Status: Not yet recruiting

Sponsored by: Consorci Sanitari de Terrassa

Official(s) and/or principal investigator(s):
Baldomero Arnau Rivera, MD, PhD, Principal Investigator, Affiliation: Consorci Sanitari de Terrassa

Overall contact:
Baldomero Arnau Rivera, MD, PhD, Phone: 0034 937314138, Email: barnau@cst.cat

Summary

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysterosalpingography diagnostic practice.

Clinical Details

Official title: Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice: a Prospective Randomized Double Blind, Placebo-controlled Clinical Trial

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Primary outcome: pain reduction in the performance of hysterosalpingography

Secondary outcome: sense of discomfort experience during the procedure

Eligibility

Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- patients that must perform a hysterosalpingography

- acceptance to participate in the study signed informed consent

Exclusion Criteria:

- hypersensitivity or allergy to anesthetics

- refusal of the patient

- patients under age 18 years old and pregnant

- unbearable pain that involves other analgesic measures

Locations and Contacts

Baldomero Arnau Rivera, MD, PhD, Phone: 0034 937314138, Email: barnau@cst.cat

Consorci Sanitari de Terrassa, Terrassa, Barcelona 08227, Spain; Not yet recruiting
Baldomero Arnau Rivera, Phone: 0034 937314138, Email: barnau@cst.cat
Baldomero Arnau Rivera, MD, PhD, Principal Investigator
Additional Information

Starting date: April 2011
Last updated: February 24, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017